Literature DB >> 21423250

Vasculitis: Risks and rewards of treating elderly patients with vasculitis.

Ruth M Tarzi, Charles D Pusey.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21423250     DOI: 10.1038/nrneph.2011.30

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.

Authors:  L Harper; C O Savage
Journal:  Rheumatology (Oxford)       Date:  2004-12-21       Impact factor: 7.580

Review 4.  Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Authors:  C Mukhtyar; R Luqmani
Journal:  Clin Exp Rheumatol       Date:  2007 Nov-Dec       Impact factor: 4.473

5.  ANCA-associated glomerulonephritis in the very elderly.

Authors:  Andrew S Bomback; Gerald B Appel; Jai Radhakrishnan; Shayan Shirazian; Leal C Herlitz; Barry Stokes; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int       Date:  2010-12-15       Impact factor: 10.612

6.  Long-term patient survival in ANCA-associated vasculitis.

Authors:  Oliver Flossmann; Annelies Berden; Kirsten de Groot; Chris Hagen; Lorraine Harper; Caroline Heijl; Peter Höglund; David Jayne; Raashid Luqmani; Alfred Mahr; Chetan Mukhtyar; Charles Pusey; Niels Rasmussen; Coen Stegeman; Michael Walsh; Kerstin Westman
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

7.  Renal biopsy in the very elderly.

Authors:  Dimitrios-Anestis Moutzouris; Leal Herlitz; Gerald B Appel; Glen S Markowitz; Bernard Freudenthal; Jai Radhakrishnan; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

8.  Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis.

Authors:  Mark A Little; Peter Nightingale; C A Verburgh; Thomas Hauser; Kirsten De Groot; Caroline Savage; David Jayne; Lorraine Harper
Journal:  Ann Rheum Dis       Date:  2009-07-01       Impact factor: 19.103

9.  Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients.

Authors:  Min Chen; Feng Yu; Ying Zhang; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2008-07       Impact factor: 1.889

10.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

  10 in total
  5 in total

Review 1.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

2.  Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Authors:  Maria Weiner; Su Mein Goh; Aladdin J Mohammad; Zdenka Hruskova; Anisha Tanna; Annette Bruchfeld; Daina Selga; Zdenka Chocova; Kerstin Westman; Per Eriksson; Charles D Pusey; Vladimir Tesar; Alan D Salama; Mårten Segelmark
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-22       Impact factor: 8.237

Review 3.  Issues in trial design for ANCA-associated and large-vessel vasculitis.

Authors:  Ruth M Tarzi; Justin C Mason; Charles D Pusey
Journal:  Nat Rev Rheumatol       Date:  2014-05-06       Impact factor: 20.543

Review 4.  Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis).

Authors:  Ruth M Tarzi; Charles D Pusey
Journal:  Ther Clin Risk Manag       Date:  2014-04-17       Impact factor: 2.423

5.  Etiological and clinicopathological study of secondary small vessel vasculitis in elderly: A case series of 12 patients.

Authors:  Ajay Kumar Mishra; Ramya Iyadurai; Anu Anna George; Ebenezer Rajdurai; V Surekha
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.